Health-care AI: Widespread Adoption, Unclear Patient Benefits

The integration of artificial intelligence into healthcare has become ubiquitous, with AI-powered tools increasingly deployed in hospitals worldwide. Doctors are leveraging AI for tasks ranging from efficient notetaking to sifting through vast patient records to flag individuals requiring specific support or treatments. Furthermore, AI is being utilized to interpret complex medical exam results and X-rays, promising enhanced accuracy and efficiency. While a growing body of research confirms the ability of many of these tools to deliver precise results, a more profound and critical question looms large: Does the widespread adoption of AI truly translate into improved health outcomes for patients? The unsettling answer, as highlighted by experts, is that we simply do not yet have sufficient evidence. This crucial knowledge gap is the central argument of a compelling paper published recently in the journal Nature Medicine, co-authored by Jenna Wiens, a computer scientist at the University of Michigan, and Anna Goldenberg of the University of Toronto. Wiens, who has dedicated years to exploring AI's potential in healthcare, notes a significant shift in recent years. Initially, she found herself pitching the technology to clinicians, but now, she observes, healthcare providers have not only become much more receptive to AI's promise but are also rapidly deploying these tools without always conducting rigorous assessments of their actual effectiveness in a clinical setting. Consider "ambient AI" tools, often referred to as AI scribes. These technologies "listen" to doctor-patient conversations, then transcribe and summarize them, and are now being widely adopted across healthcare facilities. Anecdotal evidence from medical centers suggests that doctors are "overjoyed" by these tools, as they allow them to concentrate fully on their patients during appointments and significantly reduce time-consuming administrative paperwork. Early studies even support claims that these tools can alleviate clinician burnout. However, Wiens points out a critical oversight: while researchers have evaluated provider and patient satisfaction, they have largely failed to assess how these tools impact clinical decision-making or, more importantly, patient health outcomes. "We just don’t know," she states. This uncertainty extends beyond AI scribes to other AI-based technologies designed to predict patient health trajectories or recommend treatments, all aimed at making healthcare more effective and efficient. The challenge lies in the distinction between a tool's "accuracy" and its actual benefit to patients. An AI might rapidly interpret a chest X-ray with high accuracy, but how much will a doctor rely on this analysis? How will the tool influence the doctor's interaction with patients or their treatment recommendations? Ultimately, what will this mean for the patient's well-being? These answers are complex, potentially varying across hospitals, departments, clinical workflows, and even among doctors at different career stages. Wiens also raises concerns about the cognitive impact, questioning whether AI scribes might alter how doctors process patient information or how medical students learn to interpret data, potentially leading to unintended consequences for care. The lack of comprehensive evaluation is a systemic issue. A study published in January 2025 by Paige Nong and colleagues at the University of Minnesota revealed that approximately 65% of US hospitals used AI-assisted predictive tools. Alarmingly, only two-thirds of those hospitals evaluated the accuracy of these tools, and even fewer assessed them for potential bias. Wiens emphasizes that hospitals and independent entities, not just the developing companies, must rigorously evaluate these tools' real-world impact in specific settings. While the possibility of AI leaving patients worse off is less likely, it's more probable that these tools are simply not as beneficial as healthcare providers currently assume. Despite these concerns, Wiens remains a firm believer in AI's potential to significantly enhance clinical care. She stresses that her aim is not to halt the adoption of AI in healthcare but to advocate for more transparent and evidence-based information regarding its effects on people. The future, she posits, is not an "all AI or no AI" scenario, but rather a balanced approach "somewhere in between," where thoughtful integration is guided by robust data demonstrating tangible improvements in patient care.